208
Mycobacterium tuberculosis Kompleks

1. Daniel TM. Captain of Death: The Story of Tuberculosis. Rochester: University of Rochester Press; 1999.
2. Çavuşoğlu C. History of tuberculosis and tuberculosis control program in Turkey. Microbiology Australia 2014; 35: 169-173.
3. Gagneux S. Ecology and evolution of Mycobacterium tuberculosis. Nat Rev Microbiol 2018; 16: 202-213.
4. VanderVen BC, Huang L, Rohde KH, Russell DG. The minimal unit of infection: Mycobacterium tuberculosis in the macrophage. Microbiol Spectr 2016; 4: 1-18.
5. Brosch R, Gordon SV, Eiglmeier K, et al. Genomics, Biology, and Evolution of the Mycobacterium tuberculosis Complex. In: Hatfull GF, Jacobs WR Jr; eds. Molecular Genetics of Mycobacteria.
1st ed. Washington, DC: ASM Press; 2000.
6. Ngabonziza JCS, Loiseau C, Marceau M, et al. A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region. Nat Commun 2020; 11: 1-11.
7. Coscolla M, Gagneux S, Menardo M, et al. Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history. Microbial Genomics 2021; 7: 1-14.
8. Coll F, McNerney R, Guerra-Assunçao JA, et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat Commun 2014; 5: 1-5.
9. Zwyer M, Çavusoglu C, Ghielmetti G, et al. A new nomenclature for the livestock-associated Mycobacterium tuberculosis complex based on phylogenomics. Open Research Europe 2021.
10. Gordon SV, Parish T. Microbe Profile: Mycobacterium tuberculosis: Humanity’s deadly microbial foe. Microbiology 2018; 164: 437–439.
11. Brodin P, Demangel C, Cole ST. Introduction to Functional Genomics of the Mycobacterium tuberculosis Complex. In: Cole ST, Eisenach KD, McMurray DN, Jacobs WR Jr; eds. Tuberculosis
and the Tubercle Bacillus. 1st ed. Washington, DC: ASM Press; 2005.
12. Özarslan MA. Latent tüberküloz enfeksiyonu tanısında Quantiferon-Tb Gold Plus ve tüberkülin deri testinin retrospektif olarak değerlendirilmesi. Uzmanlık tezi, İzmir-2024.
13. Gröschel MI, Sayes F, Simeone R, Majlessi L, R. ESX secretion systems: mycobacterial evolution to counter host immunity. Nature Reviews Microbiology 2016; 14: 677–691.
14. Fitzgerald DW, Sterling TR, Haas DW. Mycobacterium tuberculosis. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th
edition. Philadelphia, PA: Elsevier, Inc; 2020.
15. World Health Organization Global tuberculosis report 2023. Geneva: World Health Organization; 2023.
16. TC Sağlık Bakanlığı, Halk Sağlığı Genel Müdürlüğü, Türkiye’de Verem Savaşı 2020 Raporu. Artı6 Medya Reklam Matbaa Ltd. Şti. Ankara-2021
17. Çavuşoğlu C, Yılmaz FF. Molecular Epidemiology of Human Mycobacterium bovis Infection in Aegean Region Turkey. Mikrobiyol Bul 2017; 51: 165-170.
18. Loudon RG, Bumgarner LR, Lacy J, Coffman GK. Aerial transmission of mycobacteria. Am Rev Respir Dis 1969;100:165- 171.
19. Long R, Divangahi, M, Schwartzman K. Transmission and pathogenesis of Tuberculosis. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 2022; 6: 22–32.
20. Narasimhan P, Wood J, MacIntyre CR, Mathai D. Risk Factors for Tuberculosis. Pulmonary Medicine Volume 2013; 1-11
21. Bumbacea D, Arend SM, Eyuboglu F, et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J 2012; 40 : 990–1013.
22. Thomas TA. Tuberculosis in children. Pediatr Clin North Am 2017; 64: 893–909.
23. Lee SH. Tuberculosis Infection and Latent Tuberculosis. Tuberc Respir Dis 2016;79: 201-206.
24. Simmons JD, Stein CM, Seshadri C, et al Immunologic mechanisms of human resistance to persistent Mycobacterium tuberculosis infection. Nat Rev Immunol 2018; 18: 575-589.
25. Gong W, Wu X. Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy. Front Microbiol 2021; 12: 1-23
26. Goffinet C, Burke A, Choptiany MP. Tuberculosis: don’t miss the signs. Respiratory Medicine Today 2023; 8: 4-13.
27. Al Jahdali HH, Baharoonb S, Abba AA, et al. Saudi guidelines for testing and treatment of latent tuberculosis infection Joint Statement of the Saudi Thoracic Society, the Saudi Society of
Medical Microbiology and Infectious Diseases, the Saudi Association of Public Health, and the Society of Family and Community Medicine. Saudi Med 2010; 30: 38-49.
28. Seddon JA, Chiang SS, Esmail H, Coussensc AK. The Wonder Years: What Can Primary School Children Teach Us About Immunity to Mycobacterium tuberculosis? Frontiers in Immunology
2018; 9: 1-20.
29. Piergallini TJ, Turner J. Tuberculosis in the elderly: Why inflammation matters. Exp Gerontol 2018; 105: 32–39.
30. Sia JK, Rengarajan J. Immunology of Mycobacterium tuberculosis infections. Microbiol Spectrum 2019; 7: 1-37.
31. TC Sağlık Bakanlığı, Tüberküloz Tanı ve Tedavi Rehberi, 2. Baskı Ankara- 2019.
32. Raviglione MC, O’Brien RJ. Tüberküloz. In: Fauci AS, Kasper DL, MD, Longo DL, Braunwald E, Hauser SL, Jameson JL, Loscalzo J, eds. Harrison’s Principles of Internal Medicine Türkçe. 7th
edition. İstanbul, Nobel Tıp Kitabevleri; 2013.
33. Behr MA, Lapierre SG, Kunimoto DY, et al. Diagnosis of tuberculosis disease and drug-resistant tuberculosis. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 2022; 6:
33–48.
34. WHO operational handbook on tuberculosis. Module 3: diagnosis – rapid diagnostics for tuberculosis detention, 2021 update World Health Organization 2021.
35. Clinical and Laboratory Standards Institute. Susceptibility Testing of Mycobacteria, Nocardia Spp., and Other Aerobic Actinomycetes. 3rd edition; 2018.
36. Huang Y, Ai L, Wang X, Sun Z, Wang F. Review and Updates on the Diagnosis of Tuberculosis. J Clin Med 2022; 11: 1-14.
37. Campbell JR, Pease C, Daley P, Pai M, Menzies D. Diagnosis of tuberculosis infection. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 2022; 6: 49–65.
38. Abubakar I, Drobniewski F, Southern J, et al. Prognostic value of interferon-gamma release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT
TB): a prospective cohort study. Lancet Infect Dis. 2018;18:1077–1087.
39. WHO operational handbook on tuberculosis Tests for tuberculosis infection Module 3: Diagnosis. World Health Organization 2022.
40. Çavusoglu C, Yasar-Duman M, Isıkgoz-Tasbakan M, Tasbakan MS, Orman MN. Evaluation of the performance of QuantiFERON®-TB Gold plus test in active tuberculosis patients. J Clin
Tuberc Other Mycobact Dis 2021; 23: 1-7.
41. Unissa AN, Subbian S, Hanna LE, Selvakumar N. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis Infection, Genetics and Evolution 2016; 45:
474–492.
42. Yan W, Zheng Y, Dou C, Zhang G, Arnaout T, Cheng W. The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development. Molecular Biomedicine 2022; 3:
1-36.
43. Yang J, Zhang L, Qiao W, Youfu Luo Y. Mycobacterium tuberculosis: Pathogenesis and therapeutic targets. Med Comm 2023; 4: 1-39.
44. Cavusoglu C, Karaca-Derici Y, Bilgic A. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. Clin Microbiol Infect 2004;
10: 662-665.
45. Cavusoglu C, Turhan A, Akinci P, Soyler I. Evaluation of the Genotype MTBDR Assay for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Isolates. J Clin
Microbiol 2006; 44: 2338–2342.
46. WHO consolidated guidelines on drug-resistant tuberculosis treatment. World Health Organization 2019.
47. Judson SD, Vincent JM. Nosocomial Transmission of Emerging Viruses via Aerosol-Generating Medical Procedures. Viruses 2019; 11: 1-12.
48. Çavuşoğlu C, Edeer Karaca N, Azarsız E, Ulusoy E, Kütükçüler N. NEMO Mutasyonlu Bir Bebekten İzole Edilen Rifampisine Dirençli Mycobacterium bovis BCG Suşu. Mikrobiyol Bul 2015;
49: 272-277.
49. Avcu G, Sahbudak Bal Z, Cavusoglu C, Vardar F. Case Report Osteomyelitis Caused by BacillusCalmette-Gue΄rin Vaccinationin a Healthy Toddler. Journal of Tropical Pediatrics 2020; 66:
103–105.
50. Moorlag SJCFM, Arts RJW, van Crevel R, Netea MG. Non-specific effects of BCG vaccine on viral infections. Clin Microbiol Infect 2019; 25: 1473–1478.